Menu

AACR Apologizes for Delays in Retracting Papers

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.

Sep 5, 2018
Catherine Offord

Much of Aggarwal’s research focused on potential anticancer effects of curcumin, a chemical found in turmeric.
WIKIMEDIA, SIMON A EUGSTER 

The American Association for Cancer Research has issued retractions, corrections, or editor’s notes for a handful papers across five of its journals and is sorry for the time it’s taken to do so, according to a statement published yesterday (September 4) in Cancer Research. Nine of those retractions relate to papers coauthored by cancer researcher Bharat Aggarwal, formerly of the University of Texas’s MD Anderson Cancer Center, Retraction Watch reports.

“Unfortunately, we have been delayed in correcting the published record, and for this we apologize,” the statement reads. “We have significantly improved our procedures and processes so that, going forward, we can make these corrections to the published record in a more timely manner.”

See “More Retractions for Cancer Researcher

MD Anderson began an investigation into Aggarwal’s work in 2012; numerous papers by Aggarwal have since been retracted from journals including the Journal of Biological Chemistry and Molecular Pharmacology. Including the latest nine reports, Aggarwal—who retired from his post in 2015—has now clocked a total of 28 retractions. Eight more of his papers in AACR journals will have an editor’s note appended to them, according to Retraction Watch.

See “Seven More Retractions for Cancer Researcher

It’s not the first time AACR has dragged its feet removing papers from the literature. In July, Retraction Watch reported that several articles containing image manipulation by cancer researcher Anil Jaiswal were still available in three of AACR’s journals—nearly two years after his institution, the University of Maryland, had requested their retraction.

See “The Zombie Literature

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing